| Characterization of the anti-biofilm and anti-quorum sensing activities of the β-adrenoreceptor antagonist atenolol against Gram-negative bacterial pathogens S Cavalu, SS Elbaramawi, AG Eissa, MF Radwan, T S. Ibrahim, ... International Journal of Molecular Sciences 23 (21), 13088, 2022 | 28 | 2022 |
| Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and … AK Thabit, K Eljaaly, A Zawawi, TS Ibrahim, AG Eissa, SS Elbaramawi, ... Biology 11 (9), 1349, 2022 | 22 | 2022 |
| Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities AK Thabit, K Eljaaly, A Zawawi, TS Ibrahim, AG Eissa, SS Elbaramawi, ... Microorganisms 10 (10), 1976, 2022 | 20 | 2022 |
| Drug repositioning: Doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria MA Elfaky, SS Elbaramawi, AG Eissa, TS Ibrahim, ES Khafagy, MAM Ali, ... Applied Microbiology and Biotechnology 107 (11), 3763-3778, 2023 | 16 | 2023 |
| Targeting methionyl tRNA synthetase: design, synthesis and antibacterial activity against Clostridium difficile of novel 3-biaryl-N-benzylpropan-1-amine derivatives AG Eissa, JA Blaxland, RO Williams, KA Metwally, SM El-Adl, ... Journal of Enzyme Inhibition and Medicinal Chemistry 31 (6), 1694-1697, 2016 | 9 | 2016 |
| Design and synthesis of novel uracil-linked Schiff bases as dual histone deacetylase type II/topoisomerase type I inhibitors with apoptotic potential S El-Kalyoubi, SS Elbaramawi, AG Eissa, E Al-Ageeli, YH Hobani, ... Future Medicinal Chemistry 15 (11), 937-958, 2023 | 8 | 2023 |
| 4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors AG Eissa, D Barrow, J Gee, LE Powell, PA Foster, C Simons European Journal of Medicinal Chemistry 240, 114569, 2022 | 4 | 2022 |
| Adenine and benzimidazole-based mimics of REP-3123 as antibacterial agents against Clostridium difficile and Bacillus anthracis: design, synthesis and biological evaluation AG Eissa, JA Blaxland, RO Williams, KA Metwally, M Sobhy, ESM Lashine, ... Bulletin of Faculty of Pharmacy, Cairo University 54 (2), 197-207, 2016 | 3 | 2016 |
| S. Ibrahim, T.; Khafagy, E.-S.; Lopes, BS; Ali, MAM; Hegazy, WAH; Elfaky, MA Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor … S Cavalu, SS Elbaramawi, AG Eissa, MF Radwan Int. J. Mol. Sci, 2022 | 2 | 2022 |
| Pyridine based dual binding site aromatase (CYP19A1) inhibitors AG Eissa, LE Powell, J Gee, PA Foster, C Simons RSC Medicinal Chemistry 14 (2), 356-366, 2023 | 1 | 2023 |
| Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities. Microorganisms. 2022; 10 AK Thabit, K Eljaaly, A Zawawi, TS Ibrahim, AG Eissa, SS Elbaramawi, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| Miconazole and phenothiazine hinder the quorum sensing regulated virulence in Pseudomonas aeruginosa AI Gad, AM El-Ganiny, AG Eissa, NA Noureldin, SI Nazeih The Journal of Antibiotics, 1-12, 2024 | | 2024 |
| Modulating Pseudomonas aeruginosa virulence by the anti-cholesterol drugs Atorvastatin and Rosuvastatin SI Nazeih, AM El-Ganiny, AG Eissa, SS Elbaramawi, AI Gad | | 2024 |
| Exploring Proteus mirabilis Methionine tRNA Synthetase Active Site: Homology Model Construction, Molecular Dynamics, Pharmacophore and Docking Validation SS Elbaramawi, AG Eissa, NA Noureldin, C Simons Pharmaceuticals 16 (9), 1263, 2023 | | 2023 |
| Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria AGMA Eissa SpringerLink, 2023 | | 2023 |
| 4th Generation aromatase inhibitors for the treatment of breast cancer: design, synthesis, biochemical and molecular biology studies A Eissa Cardiff University, 2020 | | 2020 |
